A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: The DUET (Dublin Uveitis Evaluation Tool)

Annals of the Rheumatic Diseases

Volumn 74, Issue 11, 2015, Pages 1990-1995

  Haroon, Muhammad ^a   O'Rourke, Michael ^a   Ramasamy, Pathma ^b   Murphy, Conor C ^b   FitzGerald, Oliver ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS; VALIDITY; BACK PAIN; COHORT ANALYSIS; COMPLICATION; EVIDENCE BASED MEDICINE; GENETICS; MASS SCREENING; MIDDLE AGED; OPHTHALMOLOGY; PATIENT REFERRAL; PROSPECTIVE STUDY; PSORIASIS; RHEUMATOLOGY; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING;

ADULT; ALGORITHMS; BACK PAIN; COHORT STUDIES; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; FEMALE; HLA-B27 ANTIGEN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OPHTHALMOLOGY; PROSPECTIVE STUDIES; PSORIASIS; REFERRAL AND CONSULTATION; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; SPONDYLARTHROPATHIES; SPONDYLITIS, ANKYLOSING; UVEITIS, ANTERIOR;

EID: 84945198794     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205358     Document Type: Article

References (23)

1. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003;48:1126-36.
2. Rudwaleit M, Baraliakos X, Listing J, et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis before and during therapy with etanercept. Ann Rheum Dis 2005;64:305-10.
3. Baraliakos X, Davis J, Tsuji W. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 2005;52:1216-23.
4. Sullivan C, FitzGerald OM. Time to Diagnosis of Ankylosing Spondylitis in an Irish Cohort and the Effect on Work Disability [abstract]. Arthritis Rheum 2010;62(Suppl 10):555. doi:10.1002/art.28324
5. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36:766-71.
6. Feltkamp TE, Ringrose JH. Acute anterior uveitis and spondyloarthropathies. Curr Opin Rheumatol 1998;10:314-18.
7. Max R, Lorenz HM, Mackensen F. Ocular involvement in spondyloarthropathies: HLA B27 associated uveitis. Z Rheumatol 2010;69:397-402.
8. Dumbraveanu L, Cusnir V, Groppa L, et al. HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis. Oftalmologia 2010;54:29-35.
9. Huhtinen M, Karma A. HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol 2000;84:413-16.
10. Fernández-Melón J, Muñoz-Fernández S, Hidalgo V, et al. Uveitis as the initial clinical manifestation in patients with spondyloarthropathies. J Rheumatol 2004;31:524-7.
11. Pato E, Bañares A, Jover JA, et al. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis. J Rheumatol 2000;27:2198-202.
12. Rudwaleit M, Van Der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777-83.
13. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
14. Rudwaleit M, Schwarzlose S, Hilgert ES, et al. MRI in predicting a major clinical response to antitumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008;67:1276-81.
15. Giardina A, Ciccia F, Principato A, et al. Patients with short duration (5 years) ankylosing spondylitis respond rapidly and maintain partial remission over a two years period when treated with TNF-blocking agents. Ann Rheum Dis 2008;67624(Suppl II):624.
16. Barkham N, Keen HI, Coates LC, et al. Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60:946-54.
17. Braun J, Brandt J, Listing J, et al. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial. Arthritis Rheum 2003;48:2224-33.
18. Coma, Miguel Cordero, Juanola, Xavier. Prevalence of spondyloarthritis in anterior uveitis patients: the sentinel study.[abstract]. Arthritis Rheum 2012;64(Suppl 10):1700.
19. Haroon N, Inman RD, Learch TJ, et al. The impact of tumor necrosis factor a inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645-54.
20. Rudwaleit M, Listing J, Brandt J, et al. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 2004;63:665-70.
21. Haroon M, Gallagher P, Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015;74:1045-50.
22. Jois RN, Macgregor AJ, Gaffney K. Recognition of inflammatory back pain and ankylosing spondylitis in primary care. Rheumatology (Oxford) 2008;47:1364-6.
23. Van Den Berg R, De Hooge M, Rudwaleit M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis 2013;72:1646-53.